[Company Performance]: Revenue, earnings, and profit margins significantly impact investor confidence and stock valuation.

[Pharmaceutical Pipeline]: Success or failure of clinical trials for new drugs heavily influences future revenue potential and stock price.

[Debt Levels]: Bausch Health's large debt burden can make investors wary, as interest payments impact profitability and financial flexibility.

[Industry Trends]: Changes in healthcare regulations, competition from generic drugs, and market demand for specific treatments can affect Bausch Health's prospects.

[Economic Conditions]: General economic growth or recession can impact overall market sentiment and investment in pharmaceutical stocks.

[Legal Issues]: Ongoing lawsuits or regulatory investigations can create uncertainty and depress the stock price.

[Management Decisions]: Strategic decisions regarding acquisitions, divestitures, and research and development investments influence investor perception.

[Market Sentiment]: Overall investor optimism or pessimism towards the pharmaceutical sector and Bausch Health specifically affects trading activity and stock price.